Performance evaluation of mr-proadrenomedullin and other scoring systems in severe sepsis with pneumonia

Journal of Thoracic Disease

Volumn 6, Issue 7, 2014, Pages 921-929

  Akpinar, Serdar ^a   Rollas, Kazim ^a   Alagöz, Ali ^a   Seǧmen, Fatih ^a   Sipit, Tuǧrul ^a  

^a Ataturk Chest Disease and Thoracic Surgery Education and Research Hospital Ankara   (Turkey)

Author keywords

Pneumonia; Pneumonia severity index (PSI); Proadrenomedullin (proadm); Scoring systems; Sepsis

Indexed keywords

C REACTIVE PROTEIN; D DIMER; MIDREGIONAL PROADRENOMEDULLIN; PROADRENOMEDULLIN; PROCALCITONIN; UNCLASSIFIED DRUG;

ADULT; APACHE; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDREGIONAL PROADRENOMEDULLIN BLOOD LEVEL; MORTALITY; OBSERVATIONAL STUDY; PNEUMONIA SEVERITY INDEX; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE;

EID: 84905913842     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2014.06.42     Document Type: Article

References (28)

1. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-10.
2. Christ-Crain M, Morgenthaler NG, Struck J, et al. Midregional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care 2005;9:R816-24.
3. Linscheid P, Seboek D, Zulewski H, et al. Autocrine/paracrine role of inflammation-mediated calcitonin generelated peptide and adrenomedullin expression in human adipose tissue. Endocrinology 2005;146:2699-708.
4. Marutsuka K, Nawa Y, Asada Y, et al. Adrenomedullin and proadrenomudullin N-terminal 20 peptide (PAMP) are present in human colonic epithelia and exert an antimicrobial effect. Exp Physiol 2001;86:543-5.
5. Eto T. A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides. Peptides 2001;22:1693-711.
6. Nishio K, Akai Y, Murao Y, et al. Increased plasma concentrations of adrenomedullin correlate with relaxation of vascular tone in patients with septic shock. Crit Care Med 1997;25:953-7.
7. Struck J, Tao C, Morgenthaler NG, et al. Identification of an adrenomedullin precursor fragment in plasma of sepsis patients. Peptides 2004;25:1369-72.
8. Christ-Crain M, Morgenthaler NG, Stolz D, et al. Proadrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]. Crit Care 2006;10:R96.
9. Huang DT, Angus DC, Kellum JA, et al. Midregional proadrenomedullin as a prognostic tool in community acquired pneumonia. Chest 2009;136:823-31.
10. Ozlu T, Bülbül Y, Alatas F, et al. Consensus report on diagnosis and treatment of community-acquired pneumonia in adults. Toraks 2009;10:1-24. Available online: http://toraks.dergisi.org/text.php3?id=639
11. Levy MM, Fink MP, Marshall JC, et al. 2001SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-6.
12. Knaus WA, Zimmerman JE, Wagner DP, et al. APACHEacute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med 1981;9:591-7.
13. Vincent JL, de Mendonça A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 1998;26:1793-800.
14. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58:377-82.
15. Wipf JE, Lipsky BA, Hirschmann JV, et al. Diagnosing pneumonia by physical examination: relevant or relic? Arch Intern Med 1999;159:1082-7.
16. Kopterides P, Tsangaris I. Procalcitonin and sepsis: recent data on diagnostic utility prognostic potential and therapeutic implications in critically ill patients. Minerva Anestesiol 2012;78:823-35.
17. Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care 2010;14:R15.
18. Suberviola B, Castellanos-Ortega A, Llorca J, et al. Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community acquired pneumonia. Swiss Med Wkly 2012;142:w13542.
19. Brunkhorst FM, Al-Nawas B, Krummenauer F, et al. Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia. Clin Microbiol Infect 2002;8:93-100.
20. Potocki M, Breidthardt T, Reichlin T, et al. Midregional pro-Adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study. Crit Care 2009;13:R122.
21. Aronsky D, Haug PJ. Assessing the quality of clinical data in a computer-based record or calculating the pneumonia severity index. J Am Med Inform Assoc 2000;7:55-65.
22. Restrepo MI, Mortensen EM, Velez JA, et al. A comparative study of community-acquired pneumonia patients admitted to the Ward and the Intensive Care Unit. Chest 2008;133:610-7.
23. Valencia M, Badia JR, Cavalcanti M, et al. Pneumonia severity index class V patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores. Chest 2007;132:515-22.
24. Niederman MS. Making sense of scoring systems in community acquired pneumonia. Respirology 2009;14:327-35.
25. Narvaez-Rivera RM, Rendon A, Salinas-Carmona MC, et al. Soluble RAGE as a severity marker in community acquired pneumonia associated sepsis. BMC Infect Dis 2012;12:15.
26. Travaglino F, De Berardinis B, Magrini L, et al. Utility of Procalcitonin (PCT) and Mid regional pro-Adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in Emergency Department (ED). A comparison with APACHE II score. BMC Infect Dis 2012;12:184.
27. Courtais C, Kuster N, Dupuy AM, et al. Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia. Am J Emerg Med 2013;31:215-21.
28. Krüger S, Ewig S, Giersdorf S, et al. Cardiovascular and inflammatory biomarkers to predict short- and longterm survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ. Am J Respir Crit Care Med 2010;182:1426-34.